Report cover image

Global Antibacterial Vaccines Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 116 Pages
SKU # APRC20339127

Description

Summary

According to APO Research, The global Antibacterial Vaccines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Antibacterial Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Antibacterial Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Antibacterial Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Antibacterial Vaccines include Sanofi Pasteur, Novartis Vaccines, Merck & Co., Wyeth Pharmaceuticals, Inc., Protein Sciences Co., Organon Teknika Co., MedImmune LLC, MassBiologics and Intercell Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibacterial Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibacterial Vaccines.

The Antibacterial Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibacterial Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Antibacterial Vaccines Segment by Company

Sanofi Pasteur
Novartis Vaccines
Merck & Co.
Wyeth Pharmaceuticals, Inc.
Protein Sciences Co.
Organon Teknika Co.
MedImmune LLC
MassBiologics
Intercell Biomedical
ID Biomedical Co.
GlaxoSmithKline Biologicals
Emergent BioDefense Operations Lansing Inc.
Diagnostics Ltd.
CSL Ltd.
Berna Biotech
Barr Labs, Inc.
Antibacterial Vaccines Segment by Type

Conjugate Vaccines
Live/attenuated Vaccines
Inactivated Vaccines
Antibacterial Vaccines Segment by Application

Bacterial Diseases
Viral Diseases
Antibacterial Vaccines Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibacterial Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibacterial Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibacterial Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibacterial Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antibacterial Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

116 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Antibacterial Vaccines Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Antibacterial Vaccines Sales Estimates and Forecasts (2020-2031)
1.3 Antibacterial Vaccines Market by Type
1.3.1 Conjugate Vaccines
1.3.2 Live/attenuated Vaccines
1.3.3 Inactivated Vaccines
1.4 Global Antibacterial Vaccines Market Size by Type
1.4.1 Global Antibacterial Vaccines Market Size Overview by Type (2020-2031)
1.4.2 Global Antibacterial Vaccines Historic Market Size Review by Type (2020-2025)
1.4.3 Global Antibacterial Vaccines Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Antibacterial Vaccines Sales Breakdown by Type (2020-2025)
1.5.2 Europe Antibacterial Vaccines Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Antibacterial Vaccines Sales Breakdown by Type (2020-2025)
1.5.4 South America Antibacterial Vaccines Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Antibacterial Vaccines Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Antibacterial Vaccines Industry Trends
2.2 Antibacterial Vaccines Industry Drivers
2.3 Antibacterial Vaccines Industry Opportunities and Challenges
2.4 Antibacterial Vaccines Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Antibacterial Vaccines Revenue (2020-2025)
3.2 Global Top Players by Antibacterial Vaccines Sales (2020-2025)
3.3 Global Top Players by Antibacterial Vaccines Price (2020-2025)
3.4 Global Antibacterial Vaccines Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Antibacterial Vaccines Major Company Production Sites & Headquarters
3.6 Global Antibacterial Vaccines Company, Product Type & Application
3.7 Global Antibacterial Vaccines Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Antibacterial Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antibacterial Vaccines Players Market Share by Revenue in 2024
3.8.3 2023 Antibacterial Vaccines Tier 1, Tier 2, and Tier 3
4 Antibacterial Vaccines Regional Status and Outlook
4.1 Global Antibacterial Vaccines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Antibacterial Vaccines Historic Market Size by Region
4.2.1 Global Antibacterial Vaccines Sales in Volume by Region (2020-2025)
4.2.2 Global Antibacterial Vaccines Sales in Value by Region (2020-2025)
4.2.3 Global Antibacterial Vaccines Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Antibacterial Vaccines Forecasted Market Size by Region
4.3.1 Global Antibacterial Vaccines Sales in Volume by Region (2026-2031)
4.3.2 Global Antibacterial Vaccines Sales in Value by Region (2026-2031)
4.3.3 Global Antibacterial Vaccines Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Antibacterial Vaccines by Application
5.1 Antibacterial Vaccines Market by Application
5.1.1 Bacterial Diseases
5.1.2 Viral Diseases
5.2 Global Antibacterial Vaccines Market Size by Application
5.2.1 Global Antibacterial Vaccines Market Size Overview by Application (2020-2031)
5.2.2 Global Antibacterial Vaccines Historic Market Size Review by Application (2020-2025)
5.2.3 Global Antibacterial Vaccines Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Antibacterial Vaccines Sales Breakdown by Application (2020-2025)
5.3.2 Europe Antibacterial Vaccines Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Antibacterial Vaccines Sales Breakdown by Application (2020-2025)
5.3.4 South America Antibacterial Vaccines Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Antibacterial Vaccines Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Antibacterial Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 Novartis Vaccines
6.2.1 Novartis Vaccines Comapny Information
6.2.2 Novartis Vaccines Business Overview
6.2.3 Novartis Vaccines Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Vaccines Antibacterial Vaccines Product Portfolio
6.2.5 Novartis Vaccines Recent Developments
6.3 Merck & Co.
6.3.1 Merck & Co. Comapny Information
6.3.2 Merck & Co. Business Overview
6.3.3 Merck & Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co. Antibacterial Vaccines Product Portfolio
6.3.5 Merck & Co. Recent Developments
6.4 Wyeth Pharmaceuticals, Inc.
6.4.1 Wyeth Pharmaceuticals, Inc. Comapny Information
6.4.2 Wyeth Pharmaceuticals, Inc. Business Overview
6.4.3 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Product Portfolio
6.4.5 Wyeth Pharmaceuticals, Inc. Recent Developments
6.5 Protein Sciences Co.
6.5.1 Protein Sciences Co. Comapny Information
6.5.2 Protein Sciences Co. Business Overview
6.5.3 Protein Sciences Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Protein Sciences Co. Antibacterial Vaccines Product Portfolio
6.5.5 Protein Sciences Co. Recent Developments
6.6 Organon Teknika Co.
6.6.1 Organon Teknika Co. Comapny Information
6.6.2 Organon Teknika Co. Business Overview
6.6.3 Organon Teknika Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Organon Teknika Co. Antibacterial Vaccines Product Portfolio
6.6.5 Organon Teknika Co. Recent Developments
6.7 MedImmune LLC
6.7.1 MedImmune LLC Comapny Information
6.7.2 MedImmune LLC Business Overview
6.7.3 MedImmune LLC Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedImmune LLC Antibacterial Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments
6.8 MassBiologics
6.8.1 MassBiologics Comapny Information
6.8.2 MassBiologics Business Overview
6.8.3 MassBiologics Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MassBiologics Antibacterial Vaccines Product Portfolio
6.8.5 MassBiologics Recent Developments
6.9 Intercell Biomedical
6.9.1 Intercell Biomedical Comapny Information
6.9.2 Intercell Biomedical Business Overview
6.9.3 Intercell Biomedical Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Intercell Biomedical Antibacterial Vaccines Product Portfolio
6.9.5 Intercell Biomedical Recent Developments
6.10 ID Biomedical Co.
6.10.1 ID Biomedical Co. Comapny Information
6.10.2 ID Biomedical Co. Business Overview
6.10.3 ID Biomedical Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ID Biomedical Co. Antibacterial Vaccines Product Portfolio
6.10.5 ID Biomedical Co. Recent Developments
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Comapny Information
6.11.2 GlaxoSmithKline Biologicals Business Overview
6.11.3 GlaxoSmithKline Biologicals Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GlaxoSmithKline Biologicals Antibacterial Vaccines Product Portfolio
6.11.5 GlaxoSmithKline Biologicals Recent Developments
6.12 Emergent BioDefense Operations Lansing Inc.
6.12.1 Emergent BioDefense Operations Lansing Inc. Comapny Information
6.12.2 Emergent BioDefense Operations Lansing Inc. Business Overview
6.12.3 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Product Portfolio
6.12.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
6.13 Diagnostics Ltd.
6.13.1 Diagnostics Ltd. Comapny Information
6.13.2 Diagnostics Ltd. Business Overview
6.13.3 Diagnostics Ltd. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Diagnostics Ltd. Antibacterial Vaccines Product Portfolio
6.13.5 Diagnostics Ltd. Recent Developments
6.14 CSL Ltd.
6.14.1 CSL Ltd. Comapny Information
6.14.2 CSL Ltd. Business Overview
6.14.3 CSL Ltd. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CSL Ltd. Antibacterial Vaccines Product Portfolio
6.14.5 CSL Ltd. Recent Developments
6.15 Berna Biotech
6.15.1 Berna Biotech Comapny Information
6.15.2 Berna Biotech Business Overview
6.15.3 Berna Biotech Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Berna Biotech Antibacterial Vaccines Product Portfolio
6.15.5 Berna Biotech Recent Developments
6.16 Barr Labs, Inc.
6.16.1 Barr Labs, Inc. Comapny Information
6.16.2 Barr Labs, Inc. Business Overview
6.16.3 Barr Labs, Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Barr Labs, Inc. Antibacterial Vaccines Product Portfolio
6.16.5 Barr Labs, Inc. Recent Developments
7 North America by Country
7.1 North America Antibacterial Vaccines Sales by Country
7.1.1 North America Antibacterial Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Antibacterial Vaccines Sales by Country (2020-2025)
7.1.3 North America Antibacterial Vaccines Sales Forecast by Country (2026-2031)
7.2 North America Antibacterial Vaccines Market Size by Country
7.2.1 North America Antibacterial Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Antibacterial Vaccines Market Size by Country (2020-2025)
7.2.3 North America Antibacterial Vaccines Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Antibacterial Vaccines Sales by Country
8.1.1 Europe Antibacterial Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Antibacterial Vaccines Sales by Country (2020-2025)
8.1.3 Europe Antibacterial Vaccines Sales Forecast by Country (2026-2031)
8.2 Europe Antibacterial Vaccines Market Size by Country
8.2.1 Europe Antibacterial Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Antibacterial Vaccines Market Size by Country (2020-2025)
8.2.3 Europe Antibacterial Vaccines Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Antibacterial Vaccines Sales by Country
9.1.1 Asia-Pacific Antibacterial Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Antibacterial Vaccines Sales by Country (2020-2025)
9.1.3 Asia-Pacific Antibacterial Vaccines Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Antibacterial Vaccines Market Size by Country
9.2.1 Asia-Pacific Antibacterial Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Antibacterial Vaccines Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Antibacterial Vaccines Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Antibacterial Vaccines Sales by Country
10.1.1 South America Antibacterial Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Antibacterial Vaccines Sales by Country (2020-2025)
10.1.3 South America Antibacterial Vaccines Sales Forecast by Country (2026-2031)
10.2 South America Antibacterial Vaccines Market Size by Country
10.2.1 South America Antibacterial Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Antibacterial Vaccines Market Size by Country (2020-2025)
10.2.3 South America Antibacterial Vaccines Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Antibacterial Vaccines Sales by Country
11.1.1 Middle East and Africa Antibacterial Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Antibacterial Vaccines Sales by Country (2020-2025)
11.1.3 Middle East and Africa Antibacterial Vaccines Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Antibacterial Vaccines Market Size by Country
11.2.1 Middle East and Africa Antibacterial Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Antibacterial Vaccines Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Antibacterial Vaccines Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Antibacterial Vaccines Value Chain Analysis
12.1.1 Antibacterial Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Antibacterial Vaccines Production Mode & Process
12.2 Antibacterial Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Antibacterial Vaccines Distributors
12.2.3 Antibacterial Vaccines Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.